Bioventus Inc. Balance Sheet
BVS|5 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Bioventus Inc. had $684M in total assets and $184M in shareholders' equity as of FY2025. Total debt was $279M against $51M in cash, resulting in $228M net debt.
Based on SEC 10-K filings.
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | $51.2M | $41.6M | $37.0M | $30.2M | $43.9M |
| Accounts Receivable | $128.3M | $127.4M | $122.8M | $136.3M | $125.0M |
| Inventory | $82.2M | $92.5M | $91.3M | $84.8M | $61.7M |
| Current Assets | $272.8M | $275.6M | $268.0M | $272.6M | $263.1M |
| PP&E (Net) | - | - | $36.6M | $27.6M | $23.0M |
| Goodwill | $7.5M | $7.5M | $7.5M | $7.5M | $49.8M |
| Total Assets | $683.6M | $728.0M | $810.9M | $1.4B | $1.2B |
| Current Liabilities | $160.4M | $210.4M | $175.5M | $304.0M | $180.9M |
| Total Debt | $279.0M | $308.3M | $367.0M | $385.0M | $339.6M |
| Shareholders' Equity | $184.1M | $147.9M | $173.6M | $325.2M | $458.9M |